ATE287394T1 - Naphthalin-harnstoffe als glukoseaufnahme- verstärker - Google Patents

Naphthalin-harnstoffe als glukoseaufnahme- verstärker

Info

Publication number
ATE287394T1
ATE287394T1 AT00936360T AT00936360T ATE287394T1 AT E287394 T1 ATE287394 T1 AT E287394T1 AT 00936360 T AT00936360 T AT 00936360T AT 00936360 T AT00936360 T AT 00936360T AT E287394 T1 ATE287394 T1 AT E287394T1
Authority
AT
Austria
Prior art keywords
naphthaline
ureas
absorption enhancer
glucose absorption
glucose
Prior art date
Application number
AT00936360T
Other languages
English (en)
Inventor
Wayne Spevak
Robert T Lum
Songyuan Shi
Prasad Manchem
Michael R Kozlowski
Steven R Schow
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of ATE287394T1 publication Critical patent/ATE287394T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47Y being a hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/51Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/36One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4021Esters of aromatic acids (P-C aromatic linkage)
AT00936360T 1999-05-26 2000-05-25 Naphthalin-harnstoffe als glukoseaufnahme- verstärker ATE287394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13612899P 1999-05-26 1999-05-26
PCT/US2000/014644 WO2000071506A2 (en) 1999-05-26 2000-05-25 Naphthalene ureas as glucose uptake enhancers

Publications (1)

Publication Number Publication Date
ATE287394T1 true ATE287394T1 (de) 2005-02-15

Family

ID=22471427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936360T ATE287394T1 (de) 1999-05-26 2000-05-25 Naphthalin-harnstoffe als glukoseaufnahme- verstärker

Country Status (26)

Country Link
US (2) US6458998B1 (de)
EP (1) EP1181271B1 (de)
JP (1) JP2003500381A (de)
KR (1) KR100746870B1 (de)
CN (1) CN1364156A (de)
AR (1) AR024109A1 (de)
AT (1) ATE287394T1 (de)
AU (1) AU776438C (de)
BR (1) BR0011550A (de)
CA (1) CA2374225A1 (de)
CZ (1) CZ20014153A3 (de)
DE (1) DE60017554T2 (de)
EA (1) EA006763B1 (de)
ES (1) ES2233386T3 (de)
HK (1) HK1046399A1 (de)
HU (1) HUP0201306A3 (de)
IL (2) IL146576A0 (de)
MX (1) MXPA01012079A (de)
NO (1) NO20015713L (de)
NZ (1) NZ515743A (de)
PL (1) PL352631A1 (de)
TR (1) TR200103409T2 (de)
TW (1) TWI234557B (de)
UA (1) UA73738C2 (de)
WO (1) WO2000071506A2 (de)
ZA (1) ZA200109641B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7058589B1 (en) * 1998-12-17 2006-06-06 Iex Corporation Method and system for employee work scheduling
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2359244C (en) 1999-01-13 2013-10-08 Bayer Corporation .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
AU4882101A (en) 2000-04-28 2001-11-12 Shionogi & Co., Ltd. Mmp-12 inhibitors
US6528037B2 (en) 2000-10-11 2003-03-04 Telik, Inc. Method for determining whether a compound is an insulin receptor kinase activator
ITTO20010950A1 (it) * 2000-10-11 2003-04-09 Telik Inc Attivatori di recettori di insulina per il trattamento di disturbi metabolici in esseri umani che risultano dal trattamento di infezioni da
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
JP4636486B2 (ja) 2002-02-11 2011-02-23 バイエル、ファーマシューテイカルズ、コーポレイション 脈管形成阻害活性を有するアリール尿素
JP4411275B2 (ja) 2002-10-21 2010-02-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換テトラリンおよびインダンそしてこれらの使用
ATE366108T1 (de) 2003-05-20 2007-07-15 Bayer Pharmaceuticals Corp Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
PL1663978T3 (pl) 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
RU2007144076A (ru) 2005-04-28 2009-06-10 Адзиномото Ко., Инк. (Jp) Новое производное лактама
RS52010B (en) * 2005-06-22 2012-04-30 Plexxikon Inc. DERIVATI PIROLO [2, 3-B] PIRIDINA KAO INHIBITORI PROTEIN KINAZE
AU2012200933B2 (en) * 2005-06-22 2015-04-30 Plexxikon, Inc. Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors
NZ567132A (en) 2005-09-09 2011-12-22 Vertex Pharma Bicyclic derivatives as modulators of voltage gated ion channels
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CA2695004C (en) 2007-07-17 2016-01-19 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
NZ594398A (en) 2009-04-03 2014-03-28 Plexxikon Inc Propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrol [2, 3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl} -amide compositions and uses thereof
US20110112127A1 (en) 2009-11-06 2011-05-12 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
ES2696023T3 (es) 2011-02-07 2019-01-11 Plexxikon Inc Compuestos y métodos para la modulación de quinasas e indicaciones para ello
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488212A (de) * 1967-09-01 1970-03-31 Ciba Geigy Photographisches Material
US4118232A (en) * 1971-04-07 1978-10-03 Ciba-Geigy Ag Photographic material containing sulphonic acid group containing disazo dyestuffs
CA987310A (en) * 1971-04-07 1976-04-13 Ciba-Geigy Ag Azo dyestuffs, their manufacture and use
US4051176A (en) * 1976-05-10 1977-09-27 American Cyanamid Company Ureidophenylenebis(carbonylimino)dinaphthalenetrisulfonic acid compounds
US4129591A (en) * 1976-10-27 1978-12-12 American Cyanamid Company Ureida-phenylenebis(substituted imino)multianionic substituted dinaphthalene sulfonic acids and salts
US4102917A (en) * 1977-06-01 1978-07-25 American Cyanamid Company Substituted phenyl naphthalenesulfonic acids
US4132730A (en) * 1977-07-29 1979-01-02 American Cyanamid Company Ureylene naphthalene sulfonic acids
US4120891A (en) * 1977-07-01 1978-10-17 American Cyanamid Company Ureylene naphthalene sulfonic acids
JPS58191772A (ja) * 1982-05-06 1983-11-09 Canon Inc 記録液及びこれを用いたインクジェット記録方法
US4591604A (en) * 1984-03-28 1986-05-27 American Cyanamid Company Method of inhibiting the complement system by administering multisulfonated naphthalene ureas
DE19521589A1 (de) * 1995-06-14 1996-12-19 Bayer Ag Polyfunktionelle Azoreaktivfarbstoffe
US5830918A (en) * 1997-01-15 1998-11-03 Terrapin Technologies, Inc. Nonpeptide insulin receptor agonists
EP0960335B1 (de) * 1997-01-15 2005-05-25 Telik, Inc. Modulatoren von insulinrezeptor-aktivität
US6140368A (en) * 1997-05-05 2000-10-31 The Regents Of The University Of California Naphthols useful in antiviral methods

Also Published As

Publication number Publication date
IL146576A0 (en) 2002-07-25
HK1046399A1 (en) 2003-01-10
WO2000071506A2 (en) 2000-11-30
NO20015713L (no) 2001-12-20
PL352631A1 (en) 2003-08-25
ZA200109641B (en) 2003-02-24
MXPA01012079A (es) 2003-06-30
KR20020022679A (ko) 2002-03-27
DE60017554T2 (de) 2006-03-30
AU776438B2 (en) 2004-09-09
TWI234557B (en) 2005-06-21
AR024109A1 (es) 2002-09-04
HUP0201306A3 (en) 2005-04-28
IL146576A (en) 2006-10-05
KR100746870B1 (ko) 2007-08-07
BR0011550A (pt) 2002-06-04
NZ515743A (en) 2003-08-29
CA2374225A1 (en) 2000-11-30
CN1364156A (zh) 2002-08-14
EP1181271B1 (de) 2005-01-19
ES2233386T3 (es) 2005-06-16
UA73738C2 (en) 2005-09-15
US7071231B2 (en) 2006-07-04
WO2000071506A3 (en) 2001-08-09
WO2000071506A9 (en) 2001-09-20
EA200101231A1 (ru) 2002-06-27
CZ20014153A3 (cs) 2002-05-15
HUP0201306A2 (en) 2002-09-28
EP1181271A2 (de) 2002-02-27
US20030135063A1 (en) 2003-07-17
JP2003500381A (ja) 2003-01-07
EA006763B1 (ru) 2006-04-28
AU776438C (en) 2005-07-28
NO20015713D0 (no) 2001-11-23
DE60017554D1 (de) 2005-02-24
US6458998B1 (en) 2002-10-01
AU5168400A (en) 2000-12-12
TR200103409T2 (tr) 2002-05-21

Similar Documents

Publication Publication Date Title
ATE287394T1 (de) Naphthalin-harnstoffe als glukoseaufnahme- verstärker
ID29397A (id) Barang penyerap
DE60026297D1 (de) Pyrrolotriazin kinasehemmer
DE60018357D1 (de) Dachlastträger
ID28627A (id) Katalis
ID28374A (id) Bahan penyerap
DE60024631T2 (de) Biaryl-harnstoff-derivate
DE60037455D1 (de) Kinaseinhibitoren als arzneimittel
DE50013942D1 (de) Fahrzeugdach
DE60009626D1 (de) Radstruktur
DE50014686D1 (de) Fahrzeug-Cabriodachstruktur
DE60029775D1 (de) Glukose-dehydrogenase
DE19962070B4 (de) Klappdach
DE60036919D1 (de) Fahrzeug als gehhilfe
DE50012629D1 (de) Fahrzeugdach
DE50012394D1 (de) Fahrzeugdach
DE60011850D1 (de) Absorber
ATE241622T1 (de) Thiazolidindion-derivate als antidiabetika
DE60041995D1 (de) Wabenkörperstruktur
IS7421A (is) Frásogshvati
DE29901448U1 (de) Wegwerfbarer Reaktionsmodul
ATE280704T1 (de) Faltbarer fahrradrahmen
DE69902173T2 (de) Dachfahrradträger
DE29905187U1 (de) Solar-Dachkonstruktion
DE19900909B4 (de) Fahrzeug-Verdeck

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties